naltrexone has been researched along with Stroke in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Daunert, S; Deo, S; Dikici, E; Peyravian, N; Sun, E; Toborek, M | 1 |
| Amanlou, A; Dehpour, AR; Ejtemaei-Mehr, S; Eslami, F; Ghasemi, M; Rahimi, N; Rashidian, A; Shayan, M; Solaimanian, S | 1 |
| Chang, CY; Chen, CJ; Chen, WY; Hung, CJ; Kuan, YH; Liao, SL; Lin, SY; Shih, KC; Wang, WY; Wang, YY; Wu, CC | 1 |
| Liu, Y; Min, JW; Qiao, F; Wang, D; Wang, H | 1 |
| Chen, R; Guo, R; Li, H; Lin, S; Liu, M; You, C; Zheng, J | 1 |
| Abdolghaffari, AH; Aleyasin, AR; Azizi, Y; Chabouk, L; Dehpour, AR; Gooshe, M; Hassanzadeh, GR; Partoazar, A; Payandemehr, B; Tofigh, S | 1 |
| Sareen, D | 1 |
1 review(s) available for naltrexone and Stroke
| Article | Year |
|---|---|
Neuroprotective agents in acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles | 2002 |
7 other study(ies) available for naltrexone and Stroke
| Article | Year |
|---|---|
Opioid Antagonist Nanodrugs Successfully Attenuate the Severity of Ischemic Stroke.
Topics: Analgesics, Opioid; Animals; Ischemic Stroke; Mice; Morphine; Naloxone; Naltrexone; Nanoparticles; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Stroke; Tight Junction Proteins | 2022 |
Neuroprotective effects of Lasmiditan and Sumatriptan in an experimental model of post-stroke seizure in mice: Higher effects with concurrent opioid receptors or K
Topics: Adenosine Triphosphate; Animals; Anticonvulsants; bcl-2-Associated X Protein; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Glyburide; Mice; Models, Theoretical; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pentylenetetrazole; Piperidines; Potassium Channel Blockers; Potassium Channels; Pyridines; Receptors, Opioid; Seizures; Stroke; Sumatriptan; Tumor Necrosis Factor-alpha | 2022 |
β-Funaltrexamine Displayed Anti-inflammatory and Neuroprotective Effects in Cells and Rat Model of Stroke.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arginase; Brain; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Dinoprostone; Interferon-gamma; Interleukin-1beta; Lipopolysaccharides; Male; Naltrexone; Neuroglia; Neurons; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Stroke; Tumor Necrosis Factor-alpha | 2020 |
The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice.
Topics: Amyloid beta-Protein Precursor; Animals; Brain Ischemia; Cerebral Cortex; Male; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Neurons; Neuroprotective Agents; Quinolines; Receptors, Opioid, delta; Stroke | 2018 |
Neuroprotection of nalmefene for postoperative patients with spontaneous intracerebral hemorrhage.
Topics: Adult; Aged; Cerebral Hemorrhage; China; Female; Humans; Male; Middle Aged; Naltrexone; Neuroimaging; Neuroprotective Agents; Postoperative Complications; Retrospective Studies; Severity of Illness Index; Stroke; Treatment Outcome | 2015 |
Hypoxia/ischemia a key player in early post stroke seizures: modulation by opioidergic and nitrergic systems.
Topics: Analgesics, Opioid; Animals; Brain Ischemia; Cell Hypoxia; Drug Synergism; GABA Antagonists; Male; Mice; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Seizures; Stroke | 2015 |
Nalmefene. JF 1, nalmetrene, NIH 10365, ORF 11676, Arthrene, Cervene, Incystene, Revex.
Topics: Animals; Drug Overdose; Drugs, Investigational; Humans; Male; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rabbits; Stroke | 1999 |